Novel Regimen May Transform Pediatric Cystic Fibrosis Care ...Middle East

Medscape - News
Novel Regimen May Transform Pediatric Cystic Fibrosis Care
Once-daily vanzacaftor-tezacaftor-deutivacaftor was safe and well-tolerated in children with cystic fibrosis, while maintaining normal lung function, according to a 24-week phase 3 trial. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Novel Regimen May Transform Pediatric Cystic Fibrosis Care )

Also on site :



Latest News